Trial Profile
The Effects of Tetanus Vaccination on Mediators of Autoimmunity in Patients with Multiple Sclerosis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 Feb 2019
Price :
$35
*
At a glance
- Drugs DT-poliovirus vaccine (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 07 Feb 2019 Status changed from recruiting to discontinued.
- 12 Aug 2011 New trial record